ARK Genomic Revolution ETF Rating $21.40 -2.21 (-9.34%) As of 03:35 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHeadlinesHoldingsOwnershipRatingsBuy This Stock ARK Genomic Revolution ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.ARKG Aggregate RatingModerate Buy 2.73Holdings in ARKG have an aggregate rating of Moderate Buy based on 408 analyst ratings issued in the past year covering 33 companies (99.9% of the portfolio).ARKG Aggregate Price Target$21.540.65% UpsideHigh Prediction$21.54Average Prediction$21.54Low Prediction$21.54Holdings in ARKG have an aggregate price target of $21.54 and a range of $21.54 to $21.54 covering 33 companies (99.9% of the portfolio).ARKG Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy12 Buy rating(s)Moderate Buy15 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by ARK Genomic Revolution ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 33 ARKG Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings8.66%TWSTTwist Bioscience$40.09-3.6%4.0184 of 5 stars2.70$54.40 35.7%108.44%CRSPCRISPR Therapeutics$37.05-2.6%3.3006 of 5 stars2.48$73.11 97.3%217.30%RXRXRecursion Pharmaceuticals$5.79-3.1%2.1987 of 5 stars2.40$8.25 42.6%56.45%TEMTempus AI$47.31-9.0%2.5888 of 5 stars2.50$61.18 29.3%12Short Interest ↑5.61%NTRANatera$143.24-3.4%3.1295 of 5 stars3.00$178.12 24.4%16Short Interest ↑Positive News5.54%GHGuardant Health$42.93-4.9%4.2687 of 5 stars3.00$48.95 14.0%20Analyst Forecast5.36%ADPTAdaptive Biotechnologies$7.50-8.8%3.3935 of 5 stars3.00$9.40 25.4%54.86%SDGRSchrödinger$19.79-2.3%2.6295 of 5 stars3.00$32.29 63.1%84.80%BEAMBeam Therapeutics$21.96-1.0%3.2802 of 5 stars3.00$49.45 125.2%14Analyst UpgradeShort Interest ↑Positive News4.08%CDNACareDx$17.82-2.9%3.3619 of 5 stars2.57$31.83 78.6%7Positive News3.82%VCYTVeracyte$29.81-4.1%4.5499 of 5 stars2.70$43.40 45.6%10Analyst ForecastNews CoverageGap Up3.18%IONSIonis Pharmaceuticals$30.99-2.3%4.3232 of 5 stars2.70$59.44 91.8%20News Coverage2.88%TXG10x Genomics$9.12-3.1%4.7852 of 5 stars2.35$20.21 121.8%17Positive News2.71%ABSIAbsci$2.71-3.7%2.3297 of 5 stars3.00$7.60 181.0%52.70%ARCTArcturus Therapeutics$11.47-4.4%3.0888 of 5 stars3.13$59.20 416.3%8Positive News2.52%NTLAIntellia Therapeutics$8.07-4.0%4.4615 of 5 stars2.63$37.56 365.7%19Analyst Revision2.48%PSNLPersonalis$3.56-0.7%4.2245 of 5 stars3.00$7.80 119.4%5Positive News2.08%AMGNAmgen$308.00+0.7%4.4522 of 5 stars2.48$314.04 2.0%23Positive News2.02%NRIXNurix Therapeutics$12.12-3.4%2.0362 of 5 stars2.83$30.88 154.8%181.75%ILMNIllumina$79.91-2.9%4.7838 of 5 stars2.48$140.90 76.3%21Positive News1.73%BFLYButterfly Network$2.36-3.5%2.7222 of 5 stars3.00$3.00 27.4%21.50%VEEVVeeva Systems$232.10-2.3%4.3998 of 5 stars2.52$256.52 10.5%25Analyst RevisionPositive News1.37%PACBPacific Biosciences of California$1.14-8.5%2.5193 of 5 stars2.54$2.46 116.6%13Analyst ForecastShort Interest ↓News CoverageGap Down1.28%VRTXVertex Pharmaceuticals$494.24-1.7%3.8614 of 5 stars2.65$506.70 2.5%26Positive News1.21%MASS908 Devices$4.03+0.5%3.2825 of 5 stars2.50$5.33 32.3%4Short Interest ↑1.10%INCYIncyte$60.63-0.1%4.6834 of 5 stars2.21$74.88 23.5%19Positive News1.02%CERSCerus$1.41-2.4%2.3634 of 5 stars3.00$4.00 184.7%3Gap Up0.96%QSIQuantum-Si$1.26-4.2%2.9855 of 5 stars2.67$3.48 176.9%3Gap Up0.90%REGNRegeneron Pharmaceuticals$639.50+0.6%4.8259 of 5 stars2.76$973.13 52.2%25Short Interest ↑Positive News0.61%CMPSCOMPASS Pathways$2.93-5.3%3.5233 of 5 stars3.00$21.83 646.4%7Analyst ForecastPositive News0.42%PRMEPrime Medicine$1.96-2.3%2.851 of 5 stars3.10$13.38 584.1%10Gap Down0.37%LABStandard BioTools$1.11-3.1%3.079 of 5 stars2.67$2.88 160.2%3Positive News0.18%RPTXRepare Therapeutics$1.06-0.9%3.4431 of 5 stars2.50$4.50 324.5%4 This page (BATS:ARKG) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ARK Genomic Revolution ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share ARK Genomic Revolution ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ARKG Stock Free ARKG Stock Alerts